eNavvi
eNavvi is a physician-founded digital prescribing platform that enables clinicians to compare real-time medication prices across 35,000+ U.S. pharmacies and electronically prescribe compounded and standard medications. It serves individual prescribers via a free tier, EPCS subscribers, and enterprise healthcare groups seeking EHR/EMR integration.
- Company typePrivate
- Founded2023
- HeadquartersSan Jose, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What eNavvi does
eNavvi is a physician-founded digital prescribing platform that enables clinicians to compare real-time cash prices for medications across a network of more than 35,000 pharmacies in all 50 U.S. states and to transmit electronic prescriptions, including for compounded medications, directly to pharmacies. The platform targets individual prescribers (physicians, nurse practitioners, dentists, and specialists) who lack visibility into drug costs and rely on cumbersome phone/fax workflows for compounded prescriptions; secondary stakeholders include PCAB-accredited compounding pharmacies seeking prescriber access and biopharma partners seeking workflow-integrated advertising. Core technology components include an ePrescribe engine (Drummond-certified EPCS for Schedule II-V controlled substances, live on Surescripts with IAL2 identity verification and Microsoft Authenticator 2FA), a real-time price-comparison aggregator across the pharmacy network, an API integration layer for EHR/EMR and pharmacy partners, and a white-label prescriber portal for compound pharmacy networks with automated NPI/state-license credentialing and order tracking. Compliance posture is a central product feature: HIPAA certification via Vanta, SOC 2 Type II, and LegitScript approval.
The business model blends a freemium PLG motion with emerging enterprise and advertising revenue. The Core tier is free indefinitely to individual prescribers with unlimited eRx; the EPCS add-on is priced at $20/month or $200/year per prescriber; and an Enterprise tier with custom pricing targets groups, clinics, and EHR/EMR platforms with multi-year contracts, dedicated onboarding, uptime/support SLAs, and white-glove account support. A biopharma advertising dashboard provides a third revenue stream via workflow-integrated, non-disruptive advertising. Since launching in May 2024, eNavvi reports 1,200+ registered prescribers (20%+ monthly growth), 30,000+ verified monthly physician interactions, 1,700 prescriptions processed, and certifications across HIPAA, SOC 2 Type II, LegitScript, and Drummond EPCS. The company is bootstrapped, has raised approximately $840K across a November 2023 friends-and-family round ($270K), a December 2024 physician-led pre-seed ($570K), and an in-progress $1M seed (April 2025), with strategic alliances centered on ACHC (PCAB accreditation) and compounding pharmacy partners (SandsRx, Integrity Compounding, Foothills Professional Pharmacy, Cost Plus Drugs).
eNavvi firmographics
Firmographics- Name
- eNavvi
- Legal name
- eNavvi, Inc.
- Website
- https://enavvi.com
- Company type
- Private
- Founded year
- 2023
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- eNavvi is a physician-founded digital prescribing platform that enables clinicians to compare real-time medication prices across 35,000+ U.S. pharmacies and electronically prescribe compounded and standard medications. It serves individual prescribers via a free tier, EPCS subscribers, and enterprise healthcare groups seeking EHR/EMR integration.
- Ownership category
- akta.pro rank
eNavvi industry classification
Industry- Product category
- Healthcare E-Prescribing Software
- NAICS
- Software Publishers (513210)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- ePrescribing & Medication Workflow Platforms (EPCS, formulary, prior auth, med history) (HLALAIAD)
- akta.pro secondary industries
- Medication Pricing, Copay Assistance & Patient Financial Support Tools (HLACAKAN), Medication Adherence, Reminders & Patient Support (HLACAKAF), Controlled-Substance & High-Risk Medication Teleprescribing Platforms (compliance-focused) (HLALAIAM)
Keywords
Where eNavvi is headquartered
LocationHeadquarters
- HQ city
- San Jose
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
eNavvi business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Infrastructure, Operations
Revenue model
- Technology Fees: Consistent revenue from fixed fees related to platform usage, prescription handling, and associated reimbursements. Core platform is free; revenue generated from EPCS subscription tier ($20/month or $200/year) and enterprise platform fees.
- Integrated Advertising: Respectfully integrated, non-disruptive advertising within the platform generating supplemental revenue. Targeted biopharma advertising partnerships with dashboard capabilities.
- Enterprise Platform Licensing: Custom pricing and terms for EHR/EMR integration, AI agentic workflow enablement, and telemedicine capabilities sold to enterprise customers.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Monthly | Free forever plan for all prescribers with unlimited eRx |
| Subscription | Monthly | $20/month or $200/year for controlled substance prescribing |
| Subscription | Multi-year contract | Custom pricing for groups, clinics, and platforms |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels5 records
eNavvi product offering
Product offeringCore offering
eNavvi provides a web and mobile digital prescribing platform that lets clinicians compare real-time medication cash prices across 35,000+ U.S. pharmacies and electronically prescribe medications, including compounded drugs and Schedule II–V controlled substances via Drummond-certified EPCS. The offering targets physicians, nurse practitioners, and other prescribers with a free Core tier, a paid EPCS tier, and an Enterprise tier with EHR/EMR integration and AI agentic workflow enablement for groups, clinics, and platforms.
Differentiator
Problem solved
Functional benefit
Products and services
- eNavvi Core Platform
- EPCS (Electronic Prescribing of Controlled Substances)
- eNavvi Enterprise
- White-Label Prescriber Portal
- Patient Wallet
- Biopharma Advertising Dashboard
Quantifiable outcome
- Patients can save up to 82% on drug costs through price comparison
- +3 more outcomes
Companies that use eNavvi
Customer profileNamed customers6 records
Segments4 records
Ideal customer profiles4 records
eNavvi technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration4 records
Feature5 records
eNavvi partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered flagship, core and minor.
- ACHC (Accreditation Commission for Health Care)flagshipStrategic Alliance to expand PCAB-Accredited pharmacy network and build safer supply chain for compounded medications. Partnership offers reciprocal financial incentives including $1,000 discount on PCAB accreditation fees from ACHC and $1,000 credit on services from eNavvi, along with educational support and streamlined accreditation processes for member pharmacies.
- Integrity Compounding PharmacycoreTriple-accredited compounding pharmacy integration into eNavvi's curated pharmacy network. Integrity is the first facility in the Sandy Springs, Georgia region to achieve triple accreditation from ACHC covering non-sterile, sterile, and hazardous drug compounding. Expands network with access to specialized compounded medications, free shipping, and 24-hour turnaround times.
- SandsRxcoreStrategic partnership with premier independent Texas pharmacy to expand access to PCAB-accredited sterile and non-sterile compounding services for dermatology, urology, weight management, and hormone replacement therapy. SandsRx operates state-of-the-art facilities in Wylie and Frisco, Texas maintaining USP 795 and 797 compliance.
- Cost Plus DrugscoreCash price pharmacy network partner providing transparent pricing for prescription medications. Part of eNavvi's largest network of cash price pharmacies offering API-ready integration.
- StripeminorThird-party payment processor handling credit card and payment information for subscription fees and transactions through the platform.
- Foothills Professional PharmacycorePCAB-accredited pharmacy partner licensed in all 50 states providing compounded dermatology, HRT, and other specialty medications with 2-day nationwide shipping. Fulfills multiple compound formulations including scar treatments, acne medications, and hyperhidrosis formulations.
Scale indicators8 records
Recent moves6 records
Expansion highlights7 records
eNavvi competitors and assessment
Company assessmentDirect peers
- ScriptSure: Cloud-based ePrescribing and EPCS platform aimed at independent prescribers and small practices; comparable size and target customer to eNavvi's Core tier.
- DoseSpot (by PRN): ePrescribing solution used by telehealth, dental, and EMR platforms; directly competes with eNavvi on EPCS-certified prescribing and formulary/prior auth workflows.
- DrFirst: Long-standing ePrescribing and medication management platform serving hospitals, EHRs, and prescribers with EPCS, prior auth, and medication history. Closest direct competitor to eNavvi in the ePrescribing workflow layer.
- NewCrop: EHR-integrated ePrescribing and medication management vendor; competes for the same EMR-vendor channel and prescriber workflow integration business.
Emerging players
- Alto Pharmacy: Tech-enabled pharmacy with free delivery and price transparency focus; competes on the cash-pay fulfillment side of eNavvi's marketplace rather than on the prescribing side.
- RxSaver: Prescription drug price comparison and coupon platform serving underinsured consumers; overlaps with eNavvi's cash-price transparency value proposition for patients.
Broad incumbents
- Surescripts: Dominant U.S. ePrescribing network connecting virtually all pharmacies, EHRs, and prescribers; defines the EPCS backbone (which eNavvi rides) and represents the entrenched incumbent that any standalone ePrescriber must differentiate against.
- GoodRx: Consumer-facing prescription price comparison platform with provider tools; addresses the same cash-price transparency pain point as eNavvi but from a patient/consumer rather than prescriber-centric model.
- PillPack (Amazon Pharmacy): Full-service online pharmacy offering cash pricing and home delivery; competes with eNavvi's pharmacy network on fulfillment and price transparency, especially for cash-pay patients.
Others
- Cost Plus Drugs (Mark Cuban Cost Plus Drug Company): Cash-price pharmacy partner and existing eNavvi partner; comparable mission of transparent drug pricing, but operates a captive pharmacy rather than a prescriber-facing platform.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
eNavvi social profiles
Digital presenceeNavvi financial estimates
Financial estimateRevenue estimate
Valuation estimate
eNavvi leadership team
Management profileNumber of profiles
Profiles3 records
eNavvi funding detail
Funding detailFunding overview
Funding rounds4 records
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
eNavvi M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about eNavvi
What does eNavvi do?
eNavvi provides a web and mobile digital prescribing platform that lets clinicians compare real-time medication cash prices across 35,000+ U.S. pharmacies and electronically prescribe medications, including compounded drugs and Schedule II–V controlled substances via Drummond-certified EPCS. The offering targets physicians, nurse practitioners, and other prescribers with a free Core tier, a paid EPCS tier, and an Enterprise tier with EHR/EMR integration and AI agentic workflow enablement for groups, clinics, and platforms.
Is eNavvi a public or private company?
eNavvi is a private company. It is classified as venture growth investor backed and is currently operating.
When was eNavvi founded?
eNavvi was founded in 2023. It employs 11 to 50 people.
Where is eNavvi based?
eNavvi is headquartered in San Jose, United States, in the North America region.
How does eNavvi make money?
Three revenue lines are on record. Technology Fees are the primary driver. The others are integrated Advertising and enterprise Platform Licensing.
Who are eNavvi's main competitors?
Direct peers on record are ScriptSure, DoseSpot (by PRN), DrFirst and NewCrop. Emerging players are Alto Pharmacy and RxSaver. Broad incumbents are Surescripts, GoodRx and PillPack (Amazon Pharmacy). Cost Plus Drugs (Mark Cuban Cost Plus Drug Company) is listed as an others.
Does eNavvi have an API?
Yes. eNavvi offers an API ready for integration, enabling EHR/EMR platforms and other partners to integrate ePrescribing capabilities. The partnership page states 'API ready to integrate' with 'Simple, modern API documentation for fast deployment.' Pharmacy partners can integrate with the platform to receive electronic prescriptions and provide transparent cash pricing. Developer documentation is at enavvi.com/partnership.
What industry is eNavvi in?
eNavvi's product category is Healthcare E-Prescribing Software. Its primary akta.pro industry code is HLALAIAD, ePrescribing & Medication Workflow Platforms (EPCS, formulary, prior auth, med history), with a secondary code of HLACAKAN, Medication Pricing, Copay Assistance & Patient Financial Support Tools. Its NAICS code is 513210 and its SIC code is 7372.